In a separate suit against Lichtwer Pharma, one of Nutrinova’s customers, a similar judgment was announced. The first suit involves Lonza’s German sale and use of a fatty acid product currently marketed under the brand name Lonza DHA for use in functional foods and dietary supplements. The second suit involves Lichtwer’s German sale and use of DHA-containing oil in a supplement marketed under the brand name AMEU Alge. The Martek patent that has been infringed is European Patent No 0515460 relating to microbial oils containing at least 35% DHA (docosahexaenoic acid).
The court is expected to deliver its written judgments within thirty days. The patent infringed by Lonza and Lichtwer has been the subject of opposition proceedings at the European Patent Office since 1999 and a final resolution of those proceedings is expected at some time in the second half of 2008.
Steve Dubin, CEO of Martek, said: “We are very pleased that the court found that the actions of Lonza and Lichtwer infringe this European DHA patent of Martek. The decision further demonstrates both the company’s resolve to vigorously defend its intellectual property portfolio and the strength of Martek’s patent portfolio in the marketplace.”